Journal of The European Academy of Dermatology and Venereology
IF
5.25
Papers
12983
Papers 10000
1 page of 1,000 pages (10k results)
Newest
#1Chiara Cortelazzi (University of Modena and Reggio Emilia)H-Index: 6
#2M. B. de Felici del Giudice (University of Parma)
Last. S. Di Nuzzo (University of Parma)H-Index: 4
view all 0 authors...
Source
Source
Source
Source
#1Matthias Augustin (UHH: University of Hamburg)H-Index: 62
#2Claudia Garbe (UHH: University of Hamburg)
Last. Sonja StänderH-Index: 3
view all 0 authors...
BACKGROUND There are currently no published population-based data on prurigo and pruritus epidemiology in Germany. OBJECTIVES We present the prevalence, incidence, and comorbidity frequency of prurigo and pruritus in Germany. METHODS This was a retrospective healthcare research study based on anonymized routine data from the German health insurance company DAK Gesundheit. Evaluations were carried out for 2,006,003 adults who were insured as of 31 December 2010. Prurigo and pruritus diagnoses wer...
Source
#1Richard Warren (Salford Royal NHS Foundation Trust)H-Index: 51
#2Mark Lebwohl (ISMMS: Icahn School of Medicine at Mount Sinai)H-Index: 112
Last. Andrew BlauveltH-Index: 22
view all 0 authors...
BACKGROUND Certolizumab pegol (CZP) is an Fc-free, PEGylated anti-tumor necrosis factor biologic. OBJECTIVES To report three-year outcomes from the CIMPACT (NCT02346240) phase 3, CZP in moderate to severe plaque psoriasis, randomized controlled trial. METHODS Adults were randomized 3:3:3:1 to CZP 200 mg every other week (Q2W), CZP 400 mg Q2W, etanercept biweekly, or placebo. At Week 16, CZP- and etanercept-treated PASI 75 responders were re-randomized to CZP 200 mg Q2W, CZP 400 mg Q4W, CZP 400 m...
Source
#1A. Velissari (UoA: National and Kapodistrian University of Athens)
#2Eleftheria Lakiotaki (UoA: National and Kapodistrian University of Athens)H-Index: 5
Last. Marina P. Siakantaris (UoA: National and Kapodistrian University of Athens)H-Index: 24
view all 0 authors...
Source
#1Farzan Solimani (Humboldt University of Berlin)H-Index: 2
#2Yasmine Mansour (Humboldt University of Berlin)
Last. Katharina Meier (Humboldt University of Berlin)H-Index: 2
view all 0 authors...
Pemphigus vulgaris (PV) is a rare and severe autoimmune disorder of skin and mucosa. In PV, the production of autoantibodies against desmosomal proteins of the skin, namely desmoglein (Dsg) 1 and Dsg3 leads to a clinical phenotype characterized by blistering and severe erosions. Several factors including genetic susceptibility, certain drugs, and malignant disorders have been reported to trigger or exacerbate PV1 . Here, we report the first case of a patient, who developed PV following COVID-19 ...
Source
#1Akihiro Mori (Kagawa University)
#2Yo Kaku (Kagawa University)
Last. Teruki Dainichi (Kagawa University)H-Index: 26
view all 0 authors...
Source
#1M. Onaka (University of Yamanashi)
#2Hiroshi Mitsui (University of Yamanashi)H-Index: 22
Last. Tatsuyoshi Kawamura (University of Yamanashi)H-Index: 26
view all 0 authors...
Source
12345678910
Top fields of study
Surgery
Pathology
Dermatology
Disease
Psoriasis
Medicine